Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Bone Diseases × etelcalcetide hydrochloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Genitourinary 1

Conditions

Vascular Calcification 1 Neoplasm Metastasis 1 Kidney Diseases 1 Hyperparathyroidism 1 Chronic Kidney Disease-Mineral and Bone Disorder 1 Bone Diseases 1

Interventions

Zoledronic Acid 3 Denosumab 3 radium Ra 223 dichloride 1 odanacatib 1 etelcalcetide hydrochloride 1 cabozantinib 1 Standard of Care 1 Pamidronate 1 Paclitaxel 1 Exercise 1 BHQ880 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03960437 2023-09-21

Parsabiv-MBD

Columbia University

Phase 2 Completed

22 enrolled 14 charts

GenitourinaryHead & Neck

Bone Diseases, Hyperparathyroidism, Kidney Diseases, Neoplasm Metastasis, Chronic Kidney Disease-Mineral and Bone Disorder, Vascular Calcification

Data powered by HemOnc (CC BY 4.0) Colophon ⚡